Stratasys (SSYS)
(Delayed Data from NSDQ)
$8.91 USD
+0.05 (0.56%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $8.90 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SSYS 8.91 +0.05(0.56%)
Will SSYS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SSYS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SSYS
Implied Volatility Surging for Stratasys (SSYS) Stock Options
Stratasys (SSYS) Launches New Dental 3D Printer DentaJet XL
SSYS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stratasys (SSYS) Down 7% Since Last Earnings Report: Can It Rebound?
Stratasys (SSYS) Tests 3D Printed Models in Orthopedic Oncology
Stratasys (SSYS), AM Craft to Venture Into the Aviation Industry
Other News for SSYS
Stratasys unveils the DentaJetâ„¢ XL solution, designed to transform production of high-quality models for crowns and bridges, implants, clear aligner arches, and surgical guides
Stratasys Recognized at AMGTA Member Summit with Four Awards for Excellence in Additive Manufacturing Sustainable Business Practices
First patient enrolled in landmark clinical study to assess 3D printed models for orthopedic tumor removal
First Patient Enrolled in Landmark Clinical Study to Assess3D Printed Models for Orthopedic Tumor Removal
Stratasys enrolls first patient in orthopedic oncology 3D printed model study